Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Topics in Medicinal Chemistry
  4. Fast Track Articles
  5. Fast Track Article
image of 100 Years of Insulin: A Historical Perspective

Abstract

Background

Diabetes mellitus, a metabolic disease characterized by high blood glucose levels, has increased dramatically in recent years, prompting the need for more affordable diagnoses and treatments.

Objective

This study aimed to conduct a brief historical and theoretical review on the development of insulin.

Methods

Scientific and technological data have been retrieved and analyzed with a focus on the development of the active pharmaceutical ingredient insulin and insulin-based medicines. Data have been retrieved from the PubMed database available the CAPES portal.

Results

Diabetes is one of the oldest diseases in the world. The year 2021 marked the 100th anniversary of the discovery of insulin, which transformed diabetes from a fatal disease into a chronic disease. The extraction and purification of insulin from bovine or porcine pancreases from slaughterhouses has enabled the pharmaceutical industry to produce insulin on a large scale. The introduction of insulin analogs in 1996 expanded the options. Currently, commercial insulin consists of human insulin and/or human insulin analogs.

Conclusion

The state-of-the-art and technological development of insulin over the last 100 years has been presented in this work. The development of new pharmaceutical technologies has led to the obtainment of improved versions of insulin, as well as the emergence of different types of insulin. Alongside the innovations in the development of the active ingredient and related medicines, new formulations, methods, and routes of administration have emerged based on the pharmacodynamic, pharmacokinetic, and pharmacotechnical modulations of the drug.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266315941241127092613
2025-01-10
2025-06-29

  • From This Site

    /content/journals/ctmc/10.2174/0115680266315941241127092613
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Skills for innovation in the Brazilian pharmaceutical industry. 2017 Available from: https://www.cgee.org.br/-/competencias-para-inovar-na-industria-farmaceutica-brasileira
  2. Ziegler A.G. Danne T. Daniel C. Bonifacio E. 100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention. Med 2021 2 10 1120 1137 10.1016/j.medj.2021.08.003 34993499
    [Google Scholar]
  3. Foresight global health. 2021 Available from: https://foresightglobalhealth.com/addressing-the-unmet-needs-of-people-living-with-diabetes-100-years-after-the-discovery-of-insulin/Accessed on: 3/7/2021).
  4. Overcoming key barriers to quality diabetes care around the world. 2021 Available from: https://www.ifpma.org/global-health-matters/overcoming-key-barriers-to-quality-diabetes-care-around-the-world/(Accessed on: 1/07/2021).
  5. 2023 annual report. Available from: https://diabetes.org/sites/default/files/2024-06/ADA_2023_AnnualReport.pdf(Accessed on: 30/09/2024).
  6. Beran D. Mirza Z. Dong J. Access to insulin: Applying the concept of security of supply to medicines. Bull. World Health Organ. 2019 97 5 358 364 10.2471/BLT.18.217612 31551632
    [Google Scholar]
  7. Rhea E.M. Banks W.A. A historical perspective on the interactions of insulin at the blood‐brain barrier. J. Neuroendocrinol. 2021 33 4 e12929 10.1111/jne.12929 33433042
    [Google Scholar]
  8. Beran D. Lazo-Porras M. Mba C.M. Mbanya J.C. A global perspective on the issue of access to insulin. Diabetologia 2021 64 5 954 962 10.1007/s00125‑020‑05375‑2 33483763
    [Google Scholar]
  9. Classification of diabetes mellitus. 2019 Available from: https://www.who.int/publications/i/item/classification-of-diabetes-mellitus
  10. Cho N.H. Shaw J.E. Karuranga S. Huang Y. da Rocha Fernandes J.D. Ohlrogge A.W. Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018 138 271 281 10.1016/j.diabres.2018.02.023 29496507
    [Google Scholar]
  11. Long-acting analogue insulins. Available from: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2024/sociedade/relatorio-para-a-sociedade-no-489-insulinas-prolongada(Accessed on: 30/09/2024).
  12. Clinical protocol and therapeutic guidelines. 2024 Available from: https://www.gov.br/conitec/pt-br/midias/relatorios/2024/RRPCDTDM2_Final.pdf(Accessed on: 27/09/2024).
  13. Kosmas C.E. Bousvarou M.D. Kostara C.E. Papakonstantinou E.J. Salamou E. Guzman E. Insulin resistance and cardiovascular disease. J. Int. Med. Res. 2023 51 3 03000605231164548 10.1177/03000605231164548 36994866
    [Google Scholar]
  14. New W.H.A. Resolution to bring much needed boost to diabetes prevention and control efforts. 2021 Available from: https://www.who.int/news/item/27-05-2021-new-wha-resolution-to-bring-much-needed-boost-to-diabetes-prevention-and-control-efforts(Accessed on: 27/09/2024).
  15. Conte C. Cipponeri E. Roden M. Diabetes mellitus, energy metabolism, and COVID-19. Endocr. Rev. 2023 45 2 bnad032 10.1210/endrev/bnad032 37934800
    [Google Scholar]
  16. Lim S. Bae J.H. Kwon H.S. Nauck M.A. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021 17 1 11 30 10.1038/s41574‑020‑00435‑4 33188364
    [Google Scholar]
  17. Schwartz S.S. Epstein S. Corkey B.E. Grant S.F.A. Gavin J.R. Aguilar R.B. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell-centric classification schema. Diabetes Care 2016 39 2 179 186 10.2337/dc15‑1585 26798148
    [Google Scholar]
  18. Skyler J.S. Bakris G.L. Bonifacio E. Darsow T. Eckel R.H. Groop L. Groop P.H. Handelsman Y. Insel R.A. Mathieu C. McElvaine A.T. Palmer J.P. Pugliese A. Schatz D.A. Sosenko J.M. Wilding J.P.H. Ratner R.E. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 2017 66 2 241 255 10.2337/db16‑0806 27980006
    [Google Scholar]
  19. White M.F. Kahn C.R. Insulin action at a molecular level - 100 years of progress. Mol. Metab. 2021 52 101304 10.1016/j.molmet.2021.101304 34274528
    [Google Scholar]
  20. Buse J.B. Davies M.J. Frier B.M. Philis-Tsimikas A. 100 years on: The impact of the discovery of insulin on clinical outcomes. BMJ Open Diabetes Res. Care 2021 9 1 e002373 10.1136/bmjdrc‑2021‑002373 34400466
    [Google Scholar]
  21. Forst T. Choudhary P. Schneider D. Linetzky B. Pozzilli P. A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Diabetes Metab. Res. Rev. 2021 37 6 e3418 10.1002/dmrr.3418 33098260
    [Google Scholar]
  22. Rydén L. Lindsten J. The history of the Nobel prize for the discovery of insulin. Diabetes Res. Clin. Pract. 2021 175 108819 10.1016/j.diabres.2021.108819 33865917
    [Google Scholar]
  23. Dupras T.L. Williams L.J. Willems H. Peeters C. Pathological skeletal remains from ancient Egypt: The earliest case of diabetes mellitus? Pract. Diabetes Int. 2010 27 8 358 363a 10.1002/pdi.1523
    [Google Scholar]
  24. Mohamed A.H. Abbassi M.M. Sabry N.A. Knowledge, attitude, and practice of insulin among diabetic patients and pharmacists in Egypt: “Cross-sectional observational study”. BMC Med. Educ. 2024 24 1 390 10.1186/s12909‑024‑05367‑5 38594659
    [Google Scholar]
  25. King K.M. Rubin G. A history of diabetes: From antiquity to discovering insulin. Br. J. Nurs. 2003 12 18 1091 1095 10.12968/bjon.2003.12.18.11775 14581842
    [Google Scholar]
  26. Srivastava P.K. Srivastava S. Singh A.K. Dwivedi K.N. Role of Ayurveda in management of diabetes mellitus. Int. Res. J. Pharm. 2015 6 1 8 9 10.7897/2230‑8407.0613
    [Google Scholar]
  27. Laios K. Karamanou M. Saridaki Z. Androutsos G. Aretaeus of Cappadocia and the first description of diabetes. Hormones (Athens) 2012 11 1 109 113 10.1007/BF03401545 22450352
    [Google Scholar]
  28. Gull W. The Family Physician: A Manual of Domestic Medicine. London Cassell 1883 10.5962/bhl.title.27886
    [Google Scholar]
  29. Eknoyan G. Nagy J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv. Chronic Kidney Dis. 2005 12 2 223 229 10.1053/j.ackd.2005.01.002 15822058
    [Google Scholar]
  30. Masierek M. Nabrdalik K. Janota O. Kwiendacz H. Macherski M. Gumprecht J. The review of insulin pens - Past, present, and look to the future. Front. Endocrinol. (Lausanne) 2022 13 827484 10.3389/fendo.2022.827484 35355552
    [Google Scholar]
  31. National museum of American history. Available from: https://americanhistory.si.edu/(Accessed on: 6 July 2021).
  32. Bliss M. The Discovery of Insulin. Chicago University of Chicago Press 1982 10.1007/978‑1‑349‑09612‑1_9
    [Google Scholar]
  33. Leung P.S. The Renin-Angiotensin System: Current Research Progress in The Pancreas. Dordrecht Springer 2010
    [Google Scholar]
  34. Remedi M.S. Emfinger C. Pancreatic β‐cell identity in diabetes. Diabetes Obes. Metab. 2016 18 Suppl. 1 110 116 10.1111/dom.12727 27615139
    [Google Scholar]
  35. Murray I. Paulesco and the isolation of insulin. J. Hist. Med. Allied Sci. 1971 XXVI 2 150 157 10.1093/jhmas/XXVI.2.150 4930788
    [Google Scholar]
  36. Banting F.G. Best C.H. The internal secretion of the pancreas. 1922. Indian J. Med. Res. 2007 125 3 251 266 17582843
    [Google Scholar]
  37. Lewis G.F. Brubaker P.L. The discovery of insulin revisited: Lessons for the modern era. J. Clin. Invest. 2021 131 1 e142239 10.1172/JCI142239 33393501
    [Google Scholar]
  38. Leroux M. Boutchueng-Djidjou M. Faure R. Insulin’s discovery: New insights on its hundredth birthday: From insulin action and clearance to sweet networks. Int. J. Mol. Sci. 2021 22 3 1030 10.3390/ijms22031030 33494161
    [Google Scholar]
  39. Macleod J.J.R. The metabolism of the carbohydrates. Recent advances in physiology and biochemistry. Hill L. London Edward Arnold 1906 312 386
    [Google Scholar]
  40. Flier J.S. Kahn C.R. Insulin: A pacesetter for the shape of modern biomedical science and the Nobel Prize. Mol. Metab. 2021 52 101194 10.1016/j.molmet.2021.101194 33610859
    [Google Scholar]
  41. Minot G.R. Murphy W.P. Treatment of pernicious anemia by a special diet. JAMA 1926 87 7 470 476 10.1001/jama.1926.02680070016005 6358569
    [Google Scholar]
  42. Flier J.S. Starvation in the midst of plenty: Reflections on the history and biology of insulin and leptin. Endocr. Rev. 2019 40 1 1 16 10.1210/er.2018‑00179 30357355
    [Google Scholar]
  43. Šakić Z. Rudež K.D. Radoš Kajić A. Klobučar Majanović S. Rahelić D. Celebrating 100 years of insulin use. Acta Clin. Croat. 2022 61 3 482 487 10.20471/acc.2022.61.03.13 37492355
    [Google Scholar]
  44. Sanger F. The chemistry of insulin. 1958 Available from: https://www.nobelprize.org/uploads/2018/06/sanger-lecture.pdf
  45. Bilous R. Donnelly R. Handbook of Diabetes. Wiley-Blackwell 2010 10.1002/9781444391374
    [Google Scholar]
  46. Lapolla A. Dalfrà M.G. Hundred years of insulin therapy: Purified early insulins. Am. J. Ther. 2020 27 1 e24 e29 10.1097/MJT.0000000000001081 31703008
    [Google Scholar]
  47. Choi E. Bai X.C. The activation mechanism of the insulin receptor: A structural perspective. Annu. Rev. Biochem. 2023 92 1 247 272 10.1146/annurev‑biochem‑052521‑033250 37001136
    [Google Scholar]
  48. Tokarz V.L. MacDonald P.E. Klip A. The cell biology of systemic insulin function. J. Cell Biol. 2018 217 7 2273 2289 10.1083/jcb.201802095 29622564
    [Google Scholar]
  49. Gorai B. Vashisth H. Progress in simulation studies of insulin structure and function. Front. Endocrinol. (Lausanne) 2022 13 908724 10.3389/fendo.2022.908724 35795141
    [Google Scholar]
  50. Weiss M.A. Lawrence M.C. A thing of beauty: Structure and function of insulin’s “aromatic triplet”. Diabetes Obes. Metab. 2018 20 Suppl. 2 51 63 10.1111/dom.13402 30230175
    [Google Scholar]
  51. Mayer J.P. Zhang F. DiMarchi R.D. Insulin structure and function. Biopolymers 2007 88 5 687 713 10.1002/bip.20734 17410596
    [Google Scholar]
  52. Rahman M.S. Hossain K.S. Das S. Kundu S. Adegoke E.O. Rahman M.A. Hannan M.A. Uddin M.J. Pang M.G. Role of insulin in health and disease: An update. Int. J. Mol. Sci. 2021 22 12 6403 10.3390/ijms22126403 34203830
    [Google Scholar]
  53. Yudhani R.D. Sari Y. Nugrahaningsih D.A.A. Sholikhah E.N. Rochmanti M. Purba A.K.R. Khotimah H. Nugrahenny D. Mustofa M. In vitro insulin resistance model: A recent update. J. Obes. 2023 2023 1 13 10.1155/2023/1964732 36714242
    [Google Scholar]
  54. Walker J.T. Saunders D.C. Brissova M. Powers A.C. The human islet: Mini-organ with mega-impact. Endocr. Rev. 2021 42 5 605 657 10.1210/endrev/bnab010 33844836
    [Google Scholar]
  55. Andrali S.S. Sampley M.L. Vanderford N.L. Özcan S. Glucose regulation of insulin gene expression in pancreatic β-cells. Biochem. J. 2008 415 1 1 10 10.1042/BJ20081029 18778246
    [Google Scholar]
  56. Gao T. McKenna B. Li C. Reichert M. Nguyen J. Singh T. Yang C. Pannikar A. Doliba N. Zhang T. Stoffers D.A. Edlund H. Matschinsky F. Stein R. Stanger B.Z. Pdx1 maintains β cell identity and function by repressing an α cell program. Cell Metab. 2014 19 2 259 271 10.1016/j.cmet.2013.12.002 24506867
    [Google Scholar]
  57. Herman R. Sikonja J. Jensterle M. Janez A. Dolzan V. Insulin metabolism in polycystic ovary syndrome: Secretion, signaling, and clearance. Int. J. Mol. Sci. 2023 24 4 3140 10.3390/ijms24043140 36834549
    [Google Scholar]
  58. Haber E.P. Curi R. Carvalho C.R.O. Carpinelli A.R. Secreção da insulina: efeito autócrino da insulina e modulação por ácidos graxos. Arq. Bras. Endocrinol. Metabol 2001 45 3 219 227 10.1590/S0004‑27302001000300003
    [Google Scholar]
  59. Petersen M.C. Shulman G.I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 2018 98 4 2133 2223 10.1152/physrev.00063.2017 30067154
    [Google Scholar]
  60. Kebede M.A. Oler A.T. Gregg T. Balloon A.J. Johnson A. Mitok K. Rabaglia M. Schueler K. Stapleton D. Thorstenson C. Wrighton L. Floyd B.J. Richards O. Raines S. Eliceiri K. Seidah N.G. Rhodes C. Keller M.P. Coon J.L. Audhya A. Attie A.D. SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed β cells. J. Clin. Invest. 2014 124 10 4240 4256 10.1172/JCI74072 25157818
    [Google Scholar]
  61. Du W. Zhou M. Zhao W. Cheng D. Wang L. Lu J. Song E. Feng W. Xue Y. Xu P. Xu T. HID-1 is required for homotypic fusion of immature secretory granules during maturation. eLife 2016 5 e18134 10.7554/eLife.18134 27751232
    [Google Scholar]
  62. van Gerwen J. Shun-Shion A.S. Fazakerley D.J. Insulin signalling and GLUT4 trafficking in insulin resistance. Biochem. Soc. Trans. 2023 51 3 1057 1069 10.1042/BST20221066 37248992
    [Google Scholar]
  63. Oriá R.B. Brito G.A.C. Digestive System: Basic-Clinical Integration. São Paulo Blucher 2016
    [Google Scholar]
  64. Rege N.K. Liu M. Yang Y. Dhayalan B. Wickramasinghe N.P. Chen Y.S. Rahimi L. Guo H. Haataja L. Sun J. Ismail-Beigi F. Phillips N.B. Arvan P. Weiss M.A. Evolution of insulin at the edge of foldability and its medical implications. Proc. Natl. Acad. Sci. USA 2020 117 47 29618 29628 10.1073/pnas.2010908117 33154160
    [Google Scholar]
  65. Canadian intellectual property office. Available from: https://ised-isde.canada.ca/site/canadian-intellectual-property-office/en(Accessed on: 15/08/2021).
  66. Dunlop D.D. Diabetes mellitus. Thesis, University of Edinburgh Pfizer Medical Monographs 1966
    [Google Scholar]
  67. Bolli G.B. Cheng A.Y.Y. Owens D.R. Insulin: Evolution of insulin formulations and their application in clinical practice over 100 years. Acta Diabetol. 2022 59 9 1129 1144 10.1007/s00592‑022‑01938‑4 35854185
    [Google Scholar]
  68. Attie A.D. Tang Q.Q. Bornfeldt K.E. The insulin centennial - 100 years of milestones in biochemistry. J. Lipid Res. 2021 62 100132 10.1016/j.jlr.2021.100132 34717951
    [Google Scholar]
  69. Rodbard H.W. Rodbard D. Biosynthetic human insulin and insulin analogs. Am. J. Ther. 2020 27 1 e42 e51 10.1097/MJT.0000000000001089 31876563
    [Google Scholar]
  70. The discovery of insulin. 2021 Available from: https://revistapesquisa.fapesp.br/wp-content/uploads/2021/03/090-093_memoria_302.pdf(Accessed on: 18/08/2021).
  71. Pires A.C. Chacra A.R. The evolution of insulin therapy in type 1 diabetes mellitus. Arq. Bras. Endocrinol. Metabol 2008 52 2 268 278 10.1590/S0004‑27302008000200014 18438537
    [Google Scholar]
  72. Sinding C. Making the unit of insulin: Standards, clinical work, and industry, 1920-1925. Bull. Hist. Med. 2002 76 2 231 270 10.1353/bhm.2002.0097 12060790
    [Google Scholar]
  73. Cristália featured in the media. Available from: https://www.cristalia.com.br/midia/a-descoberta-da-insulina(Accessed on: 10/07/2021).
  74. Ferreira B. Public Insulin Production. Farmanguinhos Notebooks 2007
    [Google Scholar]
  75. Attie A.D. Tang Q.Q. Bornfeldt K.E. The insulin centennial - 100 years of milestones in biochemistry. J. Biol. Chem. 2021 297 5 101278 10.1016/j.jbc.2021.101278 34717954
    [Google Scholar]
  76. Sims E.K. Carr A.L.J. Oram R.A. DiMeglio L.A. Evans-Molina C. 100 years of insulin: Celebrating the past, present and future of diabetes therapy. Nat. Med. 2021 27 7 1154 1164 10.1038/s41591‑021‑01418‑2 34267380
    [Google Scholar]
  77. Junior P. Oliviera D. Pharmaceutical scenario for insulin production in Brazil. Thesis, Institute of Pharmaceutical Technology, Rio de Janeiro, 2015
    [Google Scholar]
  78. Phillip M. Nimri R. Bergenstal R.M. Barnard-Kelly K. Danne T. Hovorka R. Kovatchev B.P. Messer L.H. Parkin C.G. Ambler-Osborn L. Amiel S.A. Bally L. Beck R.W. Biester S. Biester T. Blanchette J.E. Bosi E. Boughton C.K. Breton M.D. Brown S.A. Buckingham B.A. Cai A. Carlson A.L. Castle J.R. Choudhary P. Close K.L. Cobelli C. Criego A.B. Davis E. de Beaufort C. de Bock M.I. DeSalvo D.J. DeVries J.H. Dovc K. Doyle F.J. Ekhlaspour L. Shvalb N.F. Forlenza G.P. Gallen G. Garg S.K. Gershenoff D.C. Gonder-Frederick L.A. Haidar A. Hartnell S. Heinemann L. Heller S. Hirsch I.B. Hood K.K. Isaacs D. Klonoff D.C. Kordonouri O. Kowalski A. Laffel L. Lawton J. Lal R.A. Leelarathna L. Maahs D.M. Murphy H.R. Nørgaard K. O’Neal D. Oser S. Oser T. Renard E. Riddell M.C. Rodbard D. Russell S.J. Schatz D.A. Shah V.N. Sherr J.L. Simonson G.D. Wadwa R.P. Ward C. Weinzimer S.A. Wilmot E.G. Battelino T. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr. Rev. 2023 44 2 254 280 10.1210/endrev/bnac022 36066457
    [Google Scholar]
  79. Psoma S.D. Kanthou C. Wearable insulin biosensors for diabetes management: Advances and challenges. Biosensors (Basel) 2023 13 7 719 10.3390/bios13070719 37504117
    [Google Scholar]
  80. Alves F.M. Research optimizes extraction of pre-insulin from genetically modified corn endosperm. 2004 Available from: https://unicamp.br/unicamp/unicamp_hoje/jornalPDF/ju274pag09.pdf
  81. Pereira A.J. Biotechnology in Debate EdUECE: Fortaleza 2015
    [Google Scholar]
  82. Moloney M. Cheaper insulin from transgenic plants. 2023 Available from: http://www.cib.org.br/entrevista.php?id=46 (Accessed in: June 2023)
  83. Final report: National innovation initiative. Prospective study: Future vision and INI agenda Biotechnol. 2007
    [Google Scholar]
  84. Ferreira S.B. Kaiser C.R. Junior F.P.S. Gelves L.G.V. Senger M.R. Synthesis of novel 1,2,3-triazoles derived from bergenin, compositions and use as inhibitors of glycosidase enzymes. BR Patent 102013002260-8A2 2022
  85. National Health Surveillance Agency - Anvisa Available from: https://www.gov.br/planalto/pt-br/acompanh e-o-planalto/noticias/2024/04/presidente-acompanha-retomada-da-producao-de-insulina-no-brasil-em-nova-lima-mg(Acessed on: 25/09/2024).
  86. Hoy S.M. MYL1501D insulin glargine: A review in diabetes mellitus. BioDrugs 2020 34 2 245 251 10.1007/s40259‑020‑00418‑x 32215829
    [Google Scholar]
  87. Gradel A.K.J. Porsgaard T. Lykkesfeldt J. Seested T. Gram-Nielsen S. Kristensen N.R. Refsgaard H.H.F. Factors affecting the absorption of subcutaneously administered insulin: Effect on variability. J. Diabetes Res. 2018 2018 1 17 10.1155/2018/1205121 30116732
    [Google Scholar]
  88. Hubálek F. Refsgaard H.H.F. Gram-Nielsen S. Madsen P. Nishimura E. Münzel M. Brand C.L. Stidsen C.E. Claussen C.H. Wulff E.M. Pridal L. Ribel U. Kildegaard J. Porsgaard T. Johansson E. Steensgaard D.B. Hovgaard L. Glendorf T. Hansen B.F. Jensen M.K. Nielsen P.K. Ludvigsen S. Rugh S. Garibay P.W. Moore M.C. Cherrington A.D. Kjeldsen T. Molecular engineering of safe and efficacious oral basal insulin. Nat. Commun. 2020 11 1 3746 10.1038/s41467‑020‑17487‑9 32719315
    [Google Scholar]
  89. Ong S.C. Belgi A. van Lierop B. Delaine C. Andrikopoulos S. MacRaild C.A. Norton R.S. Haworth N.L. Robinson A.J. Forbes B.E. Probing the correlation between insulin activity and structural stability through introduction of the rigid A6-A11 bond. J. Biol. Chem. 2018 293 30 11928 11943 10.1074/jbc.RA118.002486 29899115
    [Google Scholar]
  90. Zhang Y. Yu J. Kahkoska A.R. Wang J. Buse J.B. Gu Z. Advances in transdermal insulin delivery. Adv. Drug Deliv. Rev. 2019 139 51 70 10.1016/j.addr.2018.12.006 30528729
    [Google Scholar]
  91. Jarosinski M.A. Chen Y.S. Varas N. Dhayalan B. Chatterjee D. Weiss, M.A. New horizons: Next-generation insulin analogues: Structural principles and clinical goals. J. Clin. Endocrinol. Metab. 2022 107 4 909 928 10.1210/clinem/dgab849 34850005
    [Google Scholar]
  92. Lawrence M.C. Understanding insulin and its receptor from their three-dimensional structures. Mol. Metab. 2021 52 101255 10.1016/j.molmet.2021.101255 33992784
    [Google Scholar]
  93. Hirsch I.B. Juneja R. Beals J.M. Antalis C.J. Wright E.E. The evolution of insulin and how it informs therapy and treatment choices. Endocr. Rev. 2020 41 5 733 755 10.1210/endrev/bnaa015 32396624
    [Google Scholar]
  94. Long-acting insulin analogues for treatment of type 2 diabetes mellitus. 2024 Available from: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2024/relatorio-preliminar_analogos_acao_prolongada_dm2_cp63(Acessed on: 26/09/2024).
  95. Therapeutic management in type 2 diabetes: SBD algorithm. 2020 Available from: https://www.diabetes.org.br/profissionais/images/2018/posicionamento-oficial-sbd-tratamento-do-dm2-versao-final-e-definitiva-10-mai-2018.pdf(Acessed on: 17/07/2020).
  96. Duckworth W. Abraira C. Moritz T. Reda D. Emanuele N. Reaven P.D. Zieve F.J. Marks J. Davis S.N. Hayward R. Warren S.R. Goldman S. McCarren M. Vitek M.E. Henderson W.G. Huang G.D. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009 360 2 129 139 10.1056/NEJMoa0808431 19092145
    [Google Scholar]
  97. Frier B.M. Schernthaner G. Heller S.R. Hypoglycemia and cardiovascular risks. Diabetes Care 2011 34 Suppl. 2 S132 S137 10.2337/dc11‑s220 21525444
    [Google Scholar]
  98. Donner T. Muñoz M. Update on insulin therapy for type 2 diabetes. J. Clin. Endocrinol. Metab. 2012 97 5 1405 1413 10.1210/jc.2011‑2202 22442275
    [Google Scholar]
  99. Janghorbani M. Dehghani M. Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm. Cancer 2012 3 4 137 146 10.1007/s12672‑012‑0112‑z 22528451
    [Google Scholar]
  100. Gerstein H.C. Bosch J. Dagenais G.R. Díaz R. Jung H. Maggioni A.P. Pogue J. Probstfield J. Ramachandran A. Riddle M.C. Rydén L.E. Yusuf S. Basal insulin and cardiovascular and other outcomes in dysglycemia. N. Engl. J. Med. 2012 367 4 319 328 10.1056/NEJMoa1203858 22686416
    [Google Scholar]
  101. Cryer P.E. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 2013 369 4 362 372 10.1056/NEJMra1215228 23883381
    [Google Scholar]
  102. American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes - 2018. Diabetes Care 2018 41 Suppl. 1 S55 S64 10.2337/dc18‑S006 29222377
    [Google Scholar]
  103. Brazilian diabetes association 2021 Available from: https://www.diabetes.org.br/publico/diabetes/insulina(Acessed on: 25/07/2021).
  104. Donner T. Sarkar S. Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy; MDText.com, Inc.: South Dartmouth (MA) 2000 25905175
    [Google Scholar]
  105. Halberg I.B. Lyby K. Wassermann K. Heise T. Zijlstra E. Plum-Mörschel L. Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: A randomised, double-blind, phase 2 trial. Lancet Diabetes Endocrinol. 2019 7 3 179 188 10.1016/S2213‑8587(18)30372‑3 30679095
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266315941241127092613
Loading
100 Years of Insulin: A Historical Perspective
Bentham Science Publishers ; https://doi.org/10.2174/0115680266315941241127092613
/content/journals/ctmc/10.2174/0115680266315941241127092613
/content/journals/ctmc/10.2174/0115680266315941241127092613
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: diabetes ; Insulin ; pharmaceutical industry ; pharmaceutical ingredients

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test